MorphoSys AG Statistics
Total Valuation
UTI has a market cap or net worth of $1.48 billion. The enterprise value is $1.62 billion.
| Market Cap | 1.48B |
| Enterprise Value | 1.62B |
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 54.42 million shares outstanding. The number of shares has increased by 22.57% in one year.
| Current Share Class | 54.42M |
| Shares Outstanding | 54.42M |
| Shares Change (YoY) | +22.57% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 2.70% |
| Owned by Institutions (%) | 91.20% |
| Float | 52.94M |
Valuation Ratios
The trailing PE ratio is 23.83 and the forward PE ratio is 30.63. UTI's PEG ratio is 2.04.
| PE Ratio | 23.83 |
| Forward PE | 30.63 |
| PS Ratio | 1.81 |
| Forward PS | 1.67 |
| PB Ratio | 4.81 |
| P/TBV Ratio | 5.66 |
| P/FCF Ratio | 19.76 |
| P/OCF Ratio | 13.70 |
| PEG Ratio | 2.04 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.85, with an EV/FCF ratio of 21.67.
| EV / Earnings | 25.67 |
| EV / Sales | 2.00 |
| EV / EBITDA | 13.85 |
| EV / EBIT | 19.12 |
| EV / FCF | 21.67 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.00 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 1.51 |
| Debt / FCF | 3.49 |
| Interest Coverage | 12.12 |
Financial Efficiency
Return on equity (ROE) is 23.11% and return on invested capital (ROIC) is 9.45%.
| Return on Equity (ROE) | 23.11% |
| Return on Assets (ROA) | 7.32% |
| Return on Invested Capital (ROIC) | 9.45% |
| Return on Capital Employed (ROCE) | 15.24% |
| Revenue Per Employee | $218,792 |
| Profits Per Employee | $17,055 |
| Employee Count | 3,700 |
| Asset Turnover | 1.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $20.98 million in taxes.
| Income Tax | 20.98M |
| Effective Tax Rate | 24.95% |
Stock Price Statistics
The stock price has increased by +55.03% in the last 52 weeks. The beta is 1.58, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.58 |
| 52-Week Price Change | +55.03% |
| 50-Day Moving Average | 32.83 |
| 200-Day Moving Average | 27.73 |
| Relative Strength Index (RSI) | 30.64 |
| Average Volume (20 Days) | 661,793 |
Short Selling Information
The latest short interest is 2.60 million, so 4.78% of the outstanding shares have been sold short.
| Short Interest | 2.60M |
| Short Previous Month | 2.33M |
| Short % of Shares Out | 4.78% |
| Short % of Float | 4.91% |
| Short Ratio (days to cover) | 4.02 |
Income Statement
In the last 12 months, UTI had revenue of $809.53 million and earned $63.10 million in profits. Earnings per share was $1.14.
| Revenue | 809.53M |
| Gross Profit | 455.83M |
| Operating Income | 84.71M |
| Pretax Income | 40.10M |
| Net Income | 63.10M |
| EBITDA | 116.92M |
| EBIT | 84.71M |
| Earnings Per Share (EPS) | $1.14 |
Balance Sheet
The company has $117.83 million in cash and $261.01 million in debt, giving a net cash position of -$143.17 million or -$2.63 per share.
| Cash & Cash Equivalents | 117.83M |
| Total Debt | 261.01M |
| Net Cash | -143.17M |
| Net Cash Per Share | -$2.63 |
| Equity (Book Value) | 306.79M |
| Book Value Per Share | 5.64 |
| Working Capital | 155,000 |
Cash Flow
In the last 12 months, operating cash flow was $107.76 million and capital expenditures -$33.03 million, giving a free cash flow of $74.73 million.
| Operating Cash Flow | 107.76M |
| Capital Expenditures | -33.03M |
| Free Cash Flow | 74.73M |
| FCF Per Share | $1.37 |
Margins
Gross margin is 56.31%, with operating and profit margins of 10.46% and 7.79%.
| Gross Margin | 56.31% |
| Operating Margin | 10.46% |
| Pretax Margin | 10.39% |
| Profit Margin | 7.79% |
| EBITDA Margin | 14.44% |
| EBIT Margin | 10.46% |
| FCF Margin | 9.23% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.57% |
| Shareholder Yield | -22.57% |
| Earnings Yield | 4.27% |
| FCF Yield | 5.06% |
Analyst Forecast
The average price target for UTI is $34.83, which is 28.38% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.83 |
| Price Target Difference | 28.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 3.42 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.42 |
| Piotroski F-Score | 7 |